HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan G Hengstler Selected Research

senkirkine

1/2020Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jan G Hengstler Research Topics

Disease

58Neoplasms (Cancer)
07/2021 - 08/2003
30Breast Neoplasms (Breast Cancer)
01/2022 - 02/2005
21Urinary Bladder Neoplasms (Bladder Cancer)
01/2017 - 06/2008
13Liver Diseases (Liver Disease)
01/2022 - 07/2006
13Neoplasm Metastasis (Metastasis)
01/2016 - 01/2010
9Fibrosis (Cirrhosis)
01/2020 - 07/2006
7Carcinoma (Carcinomatosis)
01/2020 - 04/2010
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 01/2013
6Non-alcoholic Fatty Liver Disease
01/2022 - 10/2016
6Inflammation (Inflammations)
01/2021 - 01/2014
5Hepatocellular Carcinoma (Hepatoma)
10/2022 - 11/2010
5Cholestasis
12/2021 - 03/2016
4Necrosis
01/2020 - 09/2002
4Disease Progression
12/2018 - 04/2009
4Adenocarcinoma
01/2017 - 04/2006
4Carcinogenesis
04/2014 - 05/2002
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 04/2014
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 01/2012
3Endometrial Neoplasms (Endometrial Cancer)
01/2014 - 05/2012
3Ovarian Neoplasms (Ovarian Cancer)
10/2012 - 11/2003
3Hypoxia (Hypoxemia)
02/2011 - 06/2004
3Renal Cell Carcinoma (Grawitz Tumor)
10/2004 - 05/2002
2Acute Liver Failure (Fulminant Hepatic Failure)
01/2022 - 07/2006
2Triple Negative Breast Neoplasms
07/2021 - 09/2008
2Heart Failure
01/2020 - 12/2016
2Wounds and Injuries (Trauma)
01/2020 - 01/2016
2Alcoholic Fatty Liver
01/2020 - 04/2014
2Colonic Neoplasms (Colon Cancer)
01/2019 - 01/2012
2Fatty Liver
01/2019 - 02/2017
2Cardiotoxicity
12/2016 - 11/2016
2Prostatic Neoplasms (Prostate Cancer)
01/2016 - 05/2012
2Occupational Diseases (Occupational Disease)
01/2013 - 01/2012
1Dementia (Dementias)
03/2022
1Communicable Diseases (Infectious Diseases)
03/2022
1Cognitive Dysfunction
03/2022

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2002
11Messenger RNA (mRNA)IBA
07/2021 - 09/2005
11Estrogen ReceptorsIBA
01/2016 - 07/2008
9RNA (Ribonucleic Acid)IBA
01/2021 - 01/2010
9EnzymesIBA
01/2021 - 02/2011
9Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2008
9AcetyltransferasesIBA
01/2017 - 10/2011
8Pharmaceutical PreparationsIBA
12/2019 - 05/2003
7Biological ProductsIBA
03/2022 - 04/2009
6Immunoglobulins (Immunoglobulin)IBA
07/2021 - 01/2012
6LipidsIBA
01/2021 - 05/2010
6CarcinogensIBA
01/2018 - 11/2009
6Coal (Coals)IBA
01/2017 - 01/2012
5Phenobarbital (Luminal)FDA Link
07/2021 - 11/2010
5AnthracyclinesIBA
01/2021 - 04/2010
5AminesIBA
01/2017 - 12/2008
5DNA (Deoxyribonucleic Acid)IBA
06/2011 - 11/2002
4Choline (Choline Chloride)IBA
01/2019 - 05/2012
4glutathione S-transferase M1IBA
01/2017 - 01/2012
4IronIBA
01/2017 - 01/2012
4Doxorubicin (Adriamycin)FDA LinkGeneric
12/2016 - 07/2008
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2015 - 11/2003
3Glutathione (Reduced Glutathione)IBA
10/2022 - 01/2012
3Bile Acids and Salts (Bile Acids)IBA
01/2022 - 01/2017
3Acetaminophen (Paracetamol)FDA LinkGeneric
01/2022 - 12/2019
3LigandsIBA
12/2018 - 12/2014
3human ERBB2 proteinIBA
01/2018 - 01/2012
3Carbon Tetrachloride (Tetrachloromethane)IBA
11/2017 - 04/2014
3XenobioticsIBA
01/2017 - 12/2014
3Hormones (Hormone)IBA
08/2015 - 09/2008
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2015 - 07/2008
3Progesterone Receptors (Progesterone Receptor)IBA
12/2014 - 01/2012
3glycerophosphodiester phosphodiesteraseIBA
01/2014 - 05/2012
3Protein Isoforms (Isoforms)IBA
10/2004 - 09/2002
2Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 01/2021
2Glutamic Acid (Glutamate)FDA Link
01/2022 - 04/2016
2LipopolysaccharidesIBA
01/2022 - 01/2020
2Vinorelbine (Navelbine)FDA LinkGeneric
07/2021 - 01/2018
2Docetaxel (Taxotere)FDA Link
07/2021 - 01/2018
2Fluconazole (Zonal)FDA LinkGeneric
01/2021 - 11/2010
2InterferonsIBA
09/2020 - 07/2014
2MicroRNAs (MicroRNA)IBA
01/2020 - 12/2016
2senecionine (integerrimine)IBA
01/2020 - 01/2020
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2019 - 04/2014
2Carrier Proteins (Binding Protein)IBA
01/2019 - 07/2014
2Epidermal Growth Factor (EGF)IBA
12/2018 - 01/2017
2ErbB Receptors (EGF Receptor)IBA
12/2018 - 01/2017
2glutathione S-transferase T1IBA
01/2017 - 01/2012
2TransferasesIBA
01/2017 - 01/2012
2AmmoniaIBA
04/2016 - 12/2014
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2015 - 12/2014
2IntegrinsIBA
01/2014 - 10/2004
2CateninsIBA
10/2011 - 11/2010
2Epithelial Cell Adhesion MoleculeIBA
02/2011 - 09/2008
2Tumor Biomarkers (Tumor Markers)IBA
06/2008 - 05/2002
1Nitrofurantoin (Macrodantin)FDA LinkGeneric
10/2022
1Biological FactorsIBA
03/2022

Therapy/Procedure

21Therapeutics
01/2022 - 11/2003
6Drug Therapy (Chemotherapy)
12/2019 - 04/2006
4Transplantation
08/2008 - 05/2003
3Ligation
12/2019 - 04/2006
2Adjuvant Chemotherapy
07/2021 - 01/2018
2Neoadjuvant Therapy
01/2021 - 05/2012
2Hepatectomy
01/2018 - 10/2016
2Immunotherapy
01/2016 - 09/2008